Detection, evaluation, and management of iron-restricted erythropoiesis

被引:296
作者
Goodnough, Lawrence Tim [1 ,2 ]
Nemeth, Elizabeta [3 ,4 ]
Ganz, Tomas [3 ,4 ]
机构
[1] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA
[2] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA
[3] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA
[4] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol, Los Angeles, CA 90095 USA
关键词
RECOMBINANT-HUMAN-ERYTHROPOIETIN; RETICULOCYTE HEMOGLOBIN CONTENT; SERUM TRANSFERRIN RECEPTOR; INTRAVENOUS IRON; DEFICIENCY ANEMIA; CHRONIC DISEASE; RED-CELL; STIMULATING AGENTS; FERRIC GLUCONATE; CONTROLLED-TRIAL;
D O I
10.1182/blood-2010-05-286260
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Progress in our understanding of iron-restricted erythropoiesis has been made possible by important advances in defining the molecular mechanisms of iron homeostasis. The detection and diagnostic classification of iron-restricted erythropoiesis can be a challenging process for the clinician. Newer assays for markers of inflammation may allow more targeted management of the anemia in these conditions. The availability of new intravenous iron preparations provides new options for the treatment of iron-restricted erythropoiesis. This review summarizes recent advances regarding the detection, evaluation, and management of iron-restricted erythropoiesis. (Blood. 2010;116(23):4754-4761)
引用
收藏
页码:4754 / 4761
页数:8
相关论文
共 77 条
  • [61] Antihepcidin antibody treatment modulates iron metabolism and is effective in a mouse model of inflammation-induced anemia
    Sasu, Barbra J.
    Cooke, Keegan S.
    Arvedson, Tara L.
    Plewa, Cherylene
    Ellison, Aaron R.
    Sheng, Jackie
    Winters, Aaron
    Juan, Todd
    Li, Hongyan
    Begley, C. Glenn
    Molineux, Graham
    [J]. BLOOD, 2010, 115 (17) : 3616 - 3624
  • [62] Recombinant erythropoietin for the treatment of anemia in inflammatory bowel disease
    Schreiber, S
    Howaldt, S
    Schnoor, M
    Nikolaus, S
    Bauditz, J
    Gasche, C
    Lochs, H
    Raedler, A
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (10) : 619 - 623
  • [63] Intravenous iron supplementation for the treatment of the anemia of moderate to severe chronic renal failure patients not receiving dialysis
    Silverberg, DS
    Iaina, A
    Peer, G
    Kaplan, E
    Levi, BA
    Frank, N
    Steinbruch, S
    Blum, M
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1996, 27 (02) : 234 - 238
  • [64] SKIKNE BS, 1992, J LAB CLIN MED, V120, P746
  • [65] Tanno T., 2010, ADV HEMATOL, V2010
  • [66] Regulation of iron homeostasis in anemia of chronic disease and iron deficiency anemia: diagnostic and therapeutic implications
    Theurl, Igor
    Aigner, Elmar
    Theurl, Milan
    Nairz, Manfred
    Seifert, Markus
    Schroll, Andrea
    Sonnweber, Thomas
    Eberwein, Lukas
    Witcher, Derrick R.
    Murphy, Anthony T.
    Wroblewski, Victor J.
    Wurz, Eva
    Datz, Christian
    Weiss, Guenter
    [J]. BLOOD, 2009, 113 (21) : 5277 - 5286
  • [67] Thomas Christian, 2005, Lab Hematol, V11, P14, DOI 10.1532/LH96.04049
  • [68] Large-dose intravenous ferric carboxymaltose injection for iron deficiency anemia in heavy uterine bleeding: a randomized, controlled trial
    Van Wyck, David B.
    Mangione, Antoinette
    Morrison, John
    Hadley, Phillip Earl
    Jehle, Judi A.
    Goodnough, Lawrence Tim
    [J]. TRANSFUSION, 2009, 49 (12) : 2719 - 2728
  • [69] Inappropriate expression of hepcidin is associated with iron refractory anemia: implications for the anemia of chronic disease
    Weinstein, DA
    Roy, CN
    Fleming, MD
    Loda, MF
    Wolfsdorf, JI
    Andrews, NC
    [J]. BLOOD, 2002, 100 (10) : 3776 - 3781
  • [70] Regulation of cellular iron metabolism by erythropoietin: Activation of iron-regulatory protein and upregulation of transferrin receptor expression in erythroid cells
    Weiss, G
    Houston, T
    Kastner, S
    Johrer, K
    Grunewald, K
    Brock, JH
    [J]. BLOOD, 1997, 89 (02) : 680 - 687